2022
SARS CoV-2 seroprevalence and diagnostic accuracy during a COVID-19 outbreak in a major penitentiary complex in Brazil, June to July 2020
Gouvea-Reis F, da Silva D, Borja L, de Oliveira Dias P, Percio J, Peterka C, de Oliveira J, Sodré G, Feres C, Dos Santos W, Souza F, Teixeira A, Cilião-Alves D, Romero G, Noronha E, Croda J, Haddad R, Ramalho W, de Moraes C, de Araújo W. SARS CoV-2 seroprevalence and diagnostic accuracy during a COVID-19 outbreak in a major penitentiary complex in Brazil, June to July 2020. International Journal Of Prison Health 2022, 19: 143-156. PMID: 38899623, DOI: 10.1108/ijph-08-2021-0083.Peer-Reviewed Original ResearchSARS-CoV-2 seroprevalenceOverall infection fatality rateInfection fatality rateChemiluminescence enzyme immunoassaySymptomatic individualsOverall SARS-CoV-2 seroprevalenceSARS-CoV-2 antibodiesDiagnostic accuracyAntibody rapid testLateral flow immunochromatographic assayCOVID-19 outbreakAsymptomatic infectionVaccination strategiesEligible individualsHigh seroprevalenceFatality ratePositive casesSeroprevalenceSerological assaysEnzyme immunoassayRapid testPriority groupsMass testingLFIA testRepresentative sample
2021
Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva - Volume 27, Number 4—April 2021 - Emerging Infectious Diseases journal - CDC
Ott IM, Strine MS, Watkins AE, Boot M, Kalinich CC, Harden CA, Vogels CBF, Casanovas-Massana A, Moore AJ, Muenker MC, Nakahata M, Tokuyama M, Nelson A, Fournier J, Bermejo S, Campbell M, Datta R, Dela Cruz CS, Farhadian SF, Ko AI, Iwasaki A, Grubaugh ND, Wilen CB, Wyllie AL. Stability of SARS-CoV-2 RNA in Nonsupplemented Saliva - Volume 27, Number 4—April 2021 - Emerging Infectious Diseases journal - CDC. Emerging Infectious Diseases 2021, 27: 1146-1150. PMID: 33754989, PMCID: PMC8007305, DOI: 10.3201/eid2704.204199.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply